Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16953 | 625 | 35.4 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
17 | 4 | REPRODUCTIVE BIOLOGY//OBSTETRICS & GYNECOLOGY//VETERINARY SCIENCES | 563730 |
193 | 3 | PREECLAMPSIA//OBSTETRICS & GYNECOLOGY//REPRODUCTIVE BIOLOGY | 54114 |
679 | 2 | PREECLAMPSIA//PRE ECLAMPSIA//HYPERTENSION IN PREGNANCY | 13173 |
16953 | 1 | PLASMINOGEN ACTIVATOR INHIBITOR TYPE 2//PAI 2//SERPINB2 | 625 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PLASMINOGEN ACTIVATOR INHIBITOR TYPE 2 | authKW | 392573 | 2% | 54% | 15 |
2 | PAI 2 | authKW | 349218 | 4% | 31% | 23 |
3 | SERPINB2 | authKW | 260556 | 1% | 67% | 8 |
4 | PLASMINOGEN ACTIVATOR INHIBITOR 2 | authKW | 223133 | 2% | 35% | 13 |
5 | OVALBUMIN FAMILY | authKW | 146566 | 0% | 100% | 3 |
6 | UNITAT MED MATERNO FETAL | address | 146566 | 0% | 100% | 3 |
7 | OV SERPIN | authKW | 130278 | 1% | 67% | 4 |
8 | CLIVE WARD | address | 111029 | 1% | 45% | 5 |
9 | ANTITHROMBIN AT CONCENTRATE | authKW | 97711 | 0% | 100% | 2 |
10 | CYTOSOL INHIBITOR | authKW | 97711 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 3915 | 24% | 0% | 153 |
2 | Obstetrics & Gynecology | 3212 | 22% | 0% | 138 |
3 | Peripheral Vascular Diseases | 1859 | 16% | 0% | 103 |
4 | Biochemistry & Molecular Biology | 270 | 21% | 0% | 131 |
5 | Dentistry, Oral Surgery & Medicine | 227 | 5% | 0% | 33 |
6 | Reproductive Biology | 182 | 4% | 0% | 23 |
7 | Cell Biology | 140 | 10% | 0% | 60 |
8 | Medicine, Research & Experimental | 44 | 4% | 0% | 27 |
9 | Immunology | 37 | 6% | 0% | 35 |
10 | Biophysics | 23 | 3% | 0% | 21 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNITAT MED MATERNO FETAL | 146566 | 0% | 100% | 3 |
2 | CLIVE WARD | 111029 | 1% | 45% | 5 |
3 | VASC BIOL VB1 | 53096 | 1% | 22% | 5 |
4 | CLIN GRP GYNECOL | 48855 | 0% | 100% | 1 |
5 | CLIVE WARD BOX HILL HOSP | 48855 | 0% | 100% | 1 |
6 | EQUIPE CHROMATINE EXP S GENES ALBERT BON | 48855 | 0% | 100% | 1 |
7 | GYNECOL HUMAN REPRODUCT SCI | 48855 | 0% | 100% | 1 |
8 | HAEMOSTASIA UNIT | 48855 | 0% | 100% | 1 |
9 | HOSP LA FE BIOPATOL CLIN | 48855 | 0% | 100% | 1 |
10 | HOSP LA FE MATERNAL | 48855 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | FIBRINOLYSIS | 9129 | 2% | 2% | 11 |
2 | THROMBOSIS AND HAEMOSTASIS | 8211 | 7% | 0% | 41 |
3 | BIOLOGICAL RESEARCH IN PREGNANCY AND PERINATOLOGY | 5576 | 1% | 3% | 4 |
4 | CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY | 5324 | 1% | 2% | 5 |
5 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | 4140 | 2% | 1% | 15 |
6 | HYPERTENSION IN PREGNANCY | 3756 | 1% | 1% | 8 |
7 | GYNECOLOGIC AND OBSTETRIC INVESTIGATION | 2970 | 2% | 0% | 15 |
8 | THROMBOSIS RESEARCH | 2953 | 4% | 0% | 25 |
9 | JOURNAL OF PERIODONTAL RESEARCH | 2028 | 2% | 0% | 11 |
10 | FIBRINOLYSIS & PROTEOLYSIS | 1781 | 0% | 1% | 3 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PLASMINOGEN ACTIVATOR INHIBITOR TYPE 2 | 392573 | 2% | 54% | 15 | Search PLASMINOGEN+ACTIVATOR+INHIBITOR+TYPE+2 | Search PLASMINOGEN+ACTIVATOR+INHIBITOR+TYPE+2 |
2 | PAI 2 | 349218 | 4% | 31% | 23 | Search PAI+2 | Search PAI+2 |
3 | SERPINB2 | 260556 | 1% | 67% | 8 | Search SERPINB2 | Search SERPINB2 |
4 | PLASMINOGEN ACTIVATOR INHIBITOR 2 | 223133 | 2% | 35% | 13 | Search PLASMINOGEN+ACTIVATOR+INHIBITOR+2 | Search PLASMINOGEN+ACTIVATOR+INHIBITOR+2 |
5 | OVALBUMIN FAMILY | 146566 | 0% | 100% | 3 | Search OVALBUMIN+FAMILY | Search OVALBUMIN+FAMILY |
6 | OV SERPIN | 130278 | 1% | 67% | 4 | Search OV+SERPIN | Search OV+SERPIN |
7 | ANTITHROMBIN AT CONCENTRATE | 97711 | 0% | 100% | 2 | Search ANTITHROMBIN+AT+CONCENTRATE | Search ANTITHROMBIN+AT+CONCENTRATE |
8 | CYTOSOL INHIBITOR | 97711 | 0% | 100% | 2 | Search CYTOSOL+INHIBITOR | Search CYTOSOL+INHIBITOR |
9 | SERPINB8 | 97711 | 0% | 100% | 2 | Search SERPINB8 | Search SERPINB8 |
10 | ALPHA2 PLASMIN INHIBITOR PLASMIN COMPLEX | 87937 | 0% | 60% | 3 | Search ALPHA2+PLASMIN+INHIBITOR+PLASMIN+COMPLEX | Search ALPHA2+PLASMIN+INHIBITOR+PLASMIN+COMPLEX |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LEE, JA , COCHRAN, BJ , LOBOV, S , RANSON, M , (2011) FORTY YEARS LATER AND THE ROLE OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE 2/SERPINB2 IS STILL AN ENIGMA.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 37. ISSUE 4. P. 395-407 | 87 | 58% | 10 |
2 | SCHRODER, WA , MAJOR, L , SUHRBIER, A , (2011) THE ROLE OF SERPINB2 IN IMMUNITY.CRITICAL REVIEWS IN IMMUNOLOGY. VOL. 31. ISSUE 1. P. 15 -30 | 71 | 40% | 15 |
3 | KRUITHOF, EKO , BAKER, MS , BUNN, CL , (1995) BIOLOGICAL AND CLINICAL ASPECTS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2.BLOOD. VOL. 86. ISSUE 11. P. 4007 -4024 | 97 | 37% | 216 |
4 | MEDCALF, RL , (2011) PLASMINOGEN ACTIVATOR INHIBITOR TYPE 2: STILL AN ENIGMATIC SERPIN BUT A MODEL FOR GENE REGULATION.METHODS IN ENZYMOLOGY: BIOLOGY OF SERPINS. VOL. 499. ISSUE . P. 105-134 | 59 | 45% | 10 |
5 | MEDCALF, RL , STASINOPOULOS, SJ , (2005) THE UNDECIDED SERPIN - THE INS AND OUTS OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE 2.FEBS JOURNAL. VOL. 272. ISSUE 19. P. 4858 -4867 | 49 | 56% | 71 |
6 | DEAR, AE , MEDCALF, RL , (1995) THE CELLULAR AND MOLECULAR BIOLOGY OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-2.FIBRINOLYSIS. VOL. 9. ISSUE 6. P. 321-330 | 58 | 56% | 24 |
7 | MAJOR, L , SCHRODER, WA , GARDNER, J , FISH, RJ , SUHRBIER, A , (2011) HUMAN PAPILLOMA VIRUS TRANSFORMED CASKI CELLS CONSTITUTIVELY EXPRESS HIGH LEVELS OF FUNCTIONAL SERPINB2.EXPERIMENTAL CELL RESEARCH. VOL. 317. ISSUE 3. P. 338 -347 | 35 | 49% | 2 |
8 | SCHRODER, WA , LE, TTT , MAJOR, L , STREET, S , GARDNER, J , LAMBLEY, E , MARKEY, K , MACDONALD, KP , FISH, RJ , THOMAS, R , ET AL (2010) A PHYSIOLOGICAL FUNCTION OF INFLAMMATION-ASSOCIATED SERPINB2 IS REGULATION OF ADAPTIVE IMMUNITY.JOURNAL OF IMMUNOLOGY. VOL. 184. ISSUE 5. P. 2663-2670 | 32 | 48% | 29 |
9 | NY, T , MIKUS, P , (1997) PLASMINOGEN ACTIVATOR INHIBITOR TYPE-2 - A SPONTANEOUSLY POLYMERIZING SERPIN THAT EXISTS IN TWO TOPOLOGICAL FORMS.CHEMISTRY AND BIOLOGY OF SERPINS. VOL. 425. ISSUE . P. 123 -130 | 39 | 60% | 6 |
10 | UDOFA, EA , STRINGER, BW , GADE, P , MAHONY, D , BUZZA, MS , KALVAKOLANU, DV , ANTALIS, TM , (2013) THE TRANSCRIPTION FACTOR C/EBP-BETA MEDIATES CONSTITUTIVE AND LPS-INDUCIBLE TRANSCRIPTION OF MURINE SERPINB2.PLOS ONE. VOL. 8. ISSUE 3. P. - | 33 | 42% | 8 |
Classes with closest relation at Level 1 |